AHA today joined 27 other organizations that serve the mental, emotional and behavioral health of children in urging Congress to strengthen the pediatric mental health delivery system and infrastructure.  
 
“The effects of the COVID-19 pandemic on children’s mental health highlight the nation’s acute shortage of developmentally and culturally appropriate mental health services and the need to reinforce and expand the pediatric mental health delivery system and infrastructure,” the organizations wrote. “Congress must act now to promote access to necessary mental health care for children and adolescents by increasing immediate and long-term investments in the pediatric health care safety net, promoting comprehensive, integrated care, and building new and different national capacity to support care across the continuum.” 
 
The letter details a number of policy recommendations to address increased mental health needs for children, including bolstering the Medicaid program, extending telehealth capabilities, better care coordination and integration, promoting care in the appropriate setting and supporting the pediatric mental health workforce.
 

Related News Articles

Headline
The Centers for Disease Control and Prevention last night endorsed Moderna’s COVID-19 vaccine for children aged 6-17, as its advisory committee…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today unanimously recommended Moderna’s COVID-19 vaccine for…
Headline
The House last night voted 402-20 to pass the Restoring Hope for Mental Health and Well-being Act, bipartisan legislation that includes reauthorization through…
Blog
A recent article in the Washington Post “COVID bailout rescued some hospitals while enriching others” is wrong. The reality is that all of America’s hospitals…
Headline
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in…
Headline
More than 1 million prescriptions for the COVID-19 antiviral pills Lagevrio and Paxlovid were dispensed between late December 2021 and May 2022, but dispensing…